Search research articles
Contact Us
Filters
Showing results (1-10 of 93) with videos related to
Page
of 10
Sort By:
Bone Marrow Transplantation
|
August 25, 2023
Understanding risks and refining strategies for thromboembolism prophylaxis in hematopoietic stem cell transplant recipients
Muhamed Baljevic, Douglas W Sborov
British Journal of Haematology
|
February 5, 2013
How I manage patients with acquired haemophilia A
Douglas W Sborov, George M Rodgers
Clinical Advances in Hematology & Oncology : H&O
|
March 9, 2012
Acquired hemophilia a: a current review of autoantibody disease
Douglas W Sborov, George M Rodgers
Blood Cancer Journal
|
July 17, 2024
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era
Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
British Journal of Haematology
|
July 29, 2024
Risk-adapted treatment in multiple myeloma: Does more make it merrier?
Saurabh Zanwar, Gliceida M Galarza Fortuna, Douglas W Sborov
Therapeutic Advances in Hematology
|
July 21, 2022
Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
Mary Steinbach, Kelley Julian, Brian McClune, et al.
Expert Opinion on Investigational Drugs
|
September 17, 2014
Investigational cancer drugs targeting cell metabolism in clinical development
Douglas W Sborov, Bradley M Haverkos, Pamela J Harris
British Journal of Haematology
|
April 2, 2024
Sequence not salvage
Douglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2026
"Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT": comment from Galarza Fortuna et al
Gliceida M Galarza Fortuna, Kian J Rahbari, Muhamed Baljevic, et al.
Frontiers in Hematology
|
September 19, 2025
Exercise and Diet Studies Among Patients Living with Multiple Myeloma: Current Evidence and Considerations of Patient Preferences
Kelsey E Maslana, Grace E Skogerboe, Douglas W Sborov, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 93) with videos related to
Sort By:
Page
of 10
Bone Marrow Transplantation
|
August 25, 2023
Understanding risks and refining strategies for thromboembolism prophylaxis in hematopoietic stem cell transplant recipients
Muhamed Baljevic, Douglas W Sborov
British Journal of Haematology
|
February 5, 2013
How I manage patients with acquired haemophilia A
Douglas W Sborov, George M Rodgers
Clinical Advances in Hematology & Oncology : H&O
|
March 9, 2012
Acquired hemophilia a: a current review of autoantibody disease
Douglas W Sborov, George M Rodgers
Blood Cancer Journal
|
July 17, 2024
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era
Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
British Journal of Haematology
|
July 29, 2024
Risk-adapted treatment in multiple myeloma: Does more make it merrier?
Saurabh Zanwar, Gliceida M Galarza Fortuna, Douglas W Sborov
Therapeutic Advances in Hematology
|
July 21, 2022
Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
Mary Steinbach, Kelley Julian, Brian McClune, et al.
Expert Opinion on Investigational Drugs
|
September 17, 2014
Investigational cancer drugs targeting cell metabolism in clinical development
Douglas W Sborov, Bradley M Haverkos, Pamela J Harris
British Journal of Haematology
|
April 2, 2024
Sequence not salvage
Douglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2026
"Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT": comment from Galarza Fortuna et al
Gliceida M Galarza Fortuna, Kian J Rahbari, Muhamed Baljevic, et al.
Frontiers in Hematology
|
September 19, 2025
Exercise and Diet Studies Among Patients Living with Multiple Myeloma: Current Evidence and Considerations of Patient Preferences
Kelsey E Maslana, Grace E Skogerboe, Douglas W Sborov, et al.
Page
of 10